﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Fri, 17 Apr 2026 16:23:49 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/October-2021/rss/1912</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/October-2021/rss/1912" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-20</link><description><![CDATA[  New Drugs  

 LONAPEGSOMATROPIN-TCGD 
(SKYTROFA—Ascendis Pharma) 

  Drug class:  Human growth hormone. 

  Indication:  Pediatric patients who are at least 1 year of age who are ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-20</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2384]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Novel migraine treatments give patients more options]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/novel-migraine-treatments-give-patients-more-options</link><description><![CDATA[  Clarissa Chan, PharmD  

 In June, the American Headache Society (AHS) released an updated consensus statement to help guide health care providers in the treatment of migraine. The consensus ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/novel-migraine-treatments-give-patients-more-options</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2378]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Does melatonin have a role in prevention of vancomycin-related AKI?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/does-melatonin-have-a-role-in-prevention-of-vancomycin-related-aki</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 Melatonin use was associated with a significant reduction in vancomycin-related acute kidney injury (AKI), according to results of a single-center, retrospective ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/does-melatonin-have-a-role-in-prevention-of-vancomycin-related-aki</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2380]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Why are numerous drugs being recalled due to cancer-causing contaminants?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/why-are-numerous-drugs-being-recalled-due-to-cancer-causing-contaminants</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 Since 2018, blood pressure, diabetes, heartburn, and, most recently, smoking cessation medications have been recalled due to carcinogenic impurities called ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/why-are-numerous-drugs-being-recalled-due-to-cancer-causing-contaminants</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2381]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Maca’s therapeutic effects]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/macas-therapeutic-effects</link><description><![CDATA[  Mickie Cathers  

   

 The maca plant (Lepidium meyenii), native to the Andes of central Peru, has traditionally been used as a staple crop as one of the few plants that successfully grow in ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/macas-therapeutic-effects</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2382]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Common foot disorders]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/common-foot-disorders</link><description><![CDATA[  Daniel L. Krinsky, RPh, MS  

   

 Up to 75% of Americans will experience foot health problems at some point in their lives. Women are 4 times more likely to experience foot problems than men. ...]]></description><pubDate>Thu, 07 Oct 2021 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/common-foot-disorders</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2383]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA approves first interchangeable biosimilar insulin]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-first-interchangeable-biosimilar-insulin</link><description><![CDATA[  Maria G. Tanzi, PharmD  

 In July 2021, FDA approved the first interchangeable biosimilar insulin product (Semglee–Viatris/Biocon Biologics, insulin glargine-yfgn), which can be substituted for ...]]></description><pubDate>Mon, 07 Oct 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-first-interchangeable-biosimilar-insulin</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2379]]></dc:identifier></item></channel></rss>